Cipla opens sputum inflammometry laboratory at Mumbai lung wellness centre
This story was originally published at 09:48 IST on 4 June 2026
Register to read our real-time news.Informist, Thursday, Jun. 4, 2026
NEW DELHI – Cipla Ltd. Wednesday said it has launched a first-of-its-kind sputum inflammometry laboratory at its Breathefree Lung Wellness Center in Mumbai, Maharashtra. The laboratory will also support clinician training, respiratory research, and scientific collaboration related to sputum inflammometry in India, the company said in a press release.
Sputum inflammometry is an advanced diagnostic approach that assesses airway inflammation in patients with chronic respiratory conditions such as severe asthma, chronic obstructive pulmonary disease, and bronchiectasis. By analysing inflammatory cells and biomarkers in sputum samples, it enables more accurate diagnosis, personalised treatment, and better disease monitoring, the company said.
For the March quarter, Cipla reported consolidated net profit of INR 5.55 billion on revenues of INR 65.41 billion. At 0939 IST, shares of the company traded 0.7% lower at INR 1,366 on the National Stock Exchange. End
Reported by Gunjan Rajput
Edited by Akul Nishant Akhoury
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (11) 4220-1000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
